Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC

OCULOCUL
2 quarters

Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in OCULAR THERAPEUTIX INC

Yes. Vanguard Portfolio Management holds 1,973,130 shares of OCUL (Ocular Therapeutix), worth $19.4M, as of its Q2 2026 13F filing. It increased the position by 378,464 shares (+23.7%) from Q1 2026. Vanguard Portfolio Management has held OCUL in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$19.4M

Current Shares

2M

Total Value Change

+$5.9M

Total Shares Change

+378,464

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+23.7%
$19.4M0.0%$9.82
34
2026-Q1
First report
1.6M
-
$13.5M0.0%$8.47
0

Other major holders of OCUL: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used